Impact of Neoadjuvant Treatment and Minimally Invasive Surgery on Perioperative Outcomes of Pancreatoduodenectomy: an ACS NSQIP Analysis.
Amr I Al AbbasJennie MeierCaitlin A HesterImad RadiJinsheng YanHong ZhuJohn C MansourMatthew R PorembkaSam C WangAdam C YoppHerbert J ZehPatricio M PolancoPublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2023)
MIPD is safe and feasible after NAT. Patients having neoadjuvant chemotherapy alone followed by MIPD had lower rates of complications, shorter LOS, and fewer CR-POPFs compared to OPD.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- lymph node
- end stage renal disease
- rectal cancer
- newly diagnosed
- ejection fraction
- chronic kidney disease
- acute coronary syndrome
- sentinel lymph node
- prognostic factors
- peritoneal dialysis
- cardiac surgery
- squamous cell carcinoma
- patients undergoing
- radiation therapy
- risk factors
- metabolic syndrome
- type diabetes
- skeletal muscle
- combination therapy